Back to search

University of British Columbia

Cardiovascular risk in masters athletes

Abstract

dc:description

Background: Masters athletes (MAs) (>35y) are a rapidly growing population. While exercise has tremendous health benefits, there is a small absolute risk of major adverse cardiac events (MACE) in those with underlying cardiovascular disease (CVD). Prevention strategies, such as cardiovascular screening aim to identify CVD that may cause a MACE; however, they have not systematically been evaluated. Purpose: To assess cardiovascular risk in MAs and to determine the incidence, cost, and psychological implications of a screening program to detect CVD and prevent MACE in MAs. Methods: MAs underwent cardiovascular screening for five years. The screen consisted of anthropometrics, blood pressure, resting electrocardiogram, questionnaire, physical examination, and Framingham Risk Score (FRS). Participants with an abnormal screen underwent further evaluations. Impact of event scale-revised (IES-R) was used to determine the psychological impact in those diagnosed with CVD. Results: In the first year of the study, 799 MAs (63% male, 54.6 ± 9.5 years) were screened; 91 (11%) of the cohort were found to have CVD. CAD was the most common diagnosis (69.2%). During the following four years, there were an additional 89 CVD diagnoses with an incidence rate of 3.58/100, 4.14/100, 3.74/100, 1.19/100, for years two to five, respectively. A total of 10 MACE (0.30/100 athletes per year) occurred. All MACE occurred in male athletes (63.6±12.5 years). Increasing age (OR=1.05, 95%CI 1.00-1.09; p=0.038), FRS (%) (OR=1.09, 95%CI 1.03-1.16; p=0.003), and LDL cholesterol (mmol/L) (OR=1.71, 95% CI 1.22-2.40; p=0.002) were statistically significant in predicting the presence of CAD, whereas physical activity intensity and volume were not. The overall cost of the screening program was $603,465 or $3,063 per diagnosis. The initial screening year was the most expensive, yet had the highest number of diagnoses, thereby, had the lowest cost per diagnosis ($2,778). The median IES-R scores were within normal ranges. Conclusion: Yearly cardiovascular screening of MAs identified approximately 3 new diagnoses per 100 athletes per year. Despite this, MACE still occurred in MAs. In assessing MAs at risk of CAD FRS, age, and LDL-cholesterol should be utilized. Screening is justifiable, however, further research is required to refine the tools to decrease the cost.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Experimental Medicine
Grantor dc:publisher
University of British Columbia
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Morrison, Barbara Nicole
Contributors dc:contributor
  • Warburton, Darren E. R.

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/80113

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Morrison, Barbara Nicole. Cardiovascular risk in masters athletes. doctoral thesis, University of British Columbia, 2021. http://hdl.handle.net/2429/80113